Intellectual Property > Nova Content
The Supreme Court is taking another patent case, granting certiorari in WesternGeco v. Ion. A divided panel of the Circuit had ruled that the plaintiff was not... Read More »
Microbot Medical Inc. announced that it entered into an agreement with CardioSert Ltd. to acquire CardioSert’s patented guidewire technology, including R&D... Read More »
The big news yesterday was the Circuit’s en banc decision in Wi-Fi One v. Broadcom in which a majority of the court holds that, given the strong... Read More »
Prosecutor’s Tool Box 2017
Patent prosecutors navigate complex USPTO rules and seemingly esoteric examinational requirements to procure patent rights. In... Read More »
The World Intellectual Property Organization recently released its 2017 IP report entitled “Intangible Capital in Global Value Chains.”
The report... Read More »
In both HTC v. Cellular and Microsoft v. Biscotti, the Circuit affirms rare IPR determinations that all of the claims of the patents at issue are not invalid. In... Read More »
In Regeneron Pharmaceuticals v. Merus N.V., [16-1346] the Federal Circuit denied rehearing and rehearing en banc the July panel decision, previously discussed here... Read More »
In the recent Two-Way Media v. Comcast decision, the Federal Circuit affirmed a district court’s holding that evidence of non-obviousness was irrelevant to... Read More »
Infringement Action Waives PTAB Immunity
State-affiliated entities enjoy immunity from suit in federal courts under the 11th amendment. To date, a handful of such ... Read More »
TRAVEL SENTRY, INC., v. DAVID A. TROPP
Before Lourie, O’Malley, and Taranto. Appeal from the United States District Court for the Eastern District of... Read More »
The Federal Circuit recently faced a patent marking issue in Arctic Cat Inc. v. Bombardier Recreational Products Inc., [2017-1475] (December 8, 2017). In that... Read More »
Federal Circuit Summary
Before Dyk, Moore, and Stoll. Appeal from the Trademark Trial and Appeal Board.
Summary: The bar in § 2(a) of the... Read More »
Arctic Cat v. Bombardier deals with obviousness, patent marking, reasonable royalties, willfulness and enhanced damages. The panel affirms all of the district... Read More »
In a recent development with the ongoing complex litigation involving Janssen Biotech’s arthritis biologic medicine Remicade (infliximab) and Celltrion’s... Read More »
We do not usually report on district court cases, but the Columbia Sportswear v. Seirus design patent case handled by our firm is particularly interesting, given the... Read More »
Keeping secrets in business:
Organisations hold business-critical intangible assets that perfectly fit even the strictest definition for a valuable trade secret.
... Read More »
.In the Micron Tech case, the Circuit rules that TC Heartland changed the law on patent venue such that Micron’s argument of improper venue is now much easier... Read More »
On October 16, 2017, the Federal Circuit affirmed the district court’s ruling that the claims in Secured Mail Solutions LLC, v. Universal Wilde, Inc... Read More »
In Sanofi v. Watson Labs., the Circuit affirms a determination of induced infringement of one patent and direct infringement of another, thus assuring Sanofi another... Read More »
Inter-Partes Review (IPR) is known as an effective, relatively low cost (compared to district court litigation) and quick method used by defendants as a defense... Read More »